14 results on '"Cutarella C"'
Search Results
2. Hépatite C en milieu psychiatrique : un réservoir oublié ?
- Author
-
Rolland, B., primary, Bailly, F., additional, Cutarella, C., additional, Drevon, O., additional, Carrieri, P., additional, Darque, A., additional, Hallouche, N., additional, Maptue, N., additional, Pol, S., additional, Llorca, P.-M., additional, and Lang, J.-P., additional
- Published
- 2021
- Full Text
- View/download PDF
3. Craving, émotions et déficits d'autocontrôle
- Author
-
Cutarella, C., Bréjard, V., Cyr, L, Clinique Saint Barnabé - Ramsay Santé, Aix-Marseille Université - Faculté des Arts, Lettres, Langues et Sciences Humaines (AMU ALLSH), Aix Marseille Université (AMU), and Cyr, Laura
- Subjects
[SHS.PSY] Humanities and Social Sciences/Psychology ,digestive, oral, and skin physiology ,mental disorders ,behavior and behavior mechanisms ,[SHS.PSY]Humanities and Social Sciences/Psychology ,behavioral disciplines and activities ,psychological phenomena and processes - Abstract
The relapse into addiction and the craving represent the current massive failure of addiction management that is proposed today in clinic. The craving defined by the "irrepressible desire" to consume, is a major issue in the management of addiction in a contempory view., La rechute dans l'addiction et le phénomène de craving représentent l'échec massif actuel des prises en charge de l'addiction qui sont proposées aujourd'hui en institution. Le craving ou l' « irrépressible envie » de consommer, est un enjeu majeur dans la prise en charge de l'addiction contemporaine.
- Published
- 2019
4. [Hepatitis C in a psychiatric setting: A forgotten reservoir?]
- Author
-
Rolland, B, Bailly, F, Cutarella, C, Drevon, O, Carrieri, P, Darque, A, Hallouche, N, Maptue, N, Pol, S, Llorca, P-M, Lang, J-P, Service Universitaire d’Addictologie de Lyon [CH Le Vinatier, Bron] (Pôle MOPHA - SUAL), Centre Hospitalier le Vinatier [Bron], Service d'Hépatologie [Hôpital de la Croix-Rousse - HCL], Hôpital de la Croix-Rousse [CHU - HCL], Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Clinique Saint Barnabé - Ramsay Santé [Marseille] (CSB-RS), Santé basque développement [Bayonne], Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Observatoire régional de la santé Provence-Alpes-Côte d'Azur [Marseille] (ORS PACA), Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), GHU Paris Psychiatrie et Neurosciences, Association nationale pour la promotion des soins somatiques en santé mentale [Paris] (ANP3SM), Centre mutualiste d'addictologie de Saint-Galmier [Saint-Etienne] (Mutualité française Loire - Haute Loire SSAM), Service d'hépatologie médicale [CHU Cochin], Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunité Innée - Innate Immunity, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Neuro-Psycho Pharmacologie des Systèmes Dopimanégiques sous-corticaux (NPsy-Sydo), CHU Clermont-Ferrand-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), Les Toises Centre de Psychiatrie et Psychothérapie [Lausanne, Suisse], Centre d'information régional sur les drogues et dépendances Alsace [Strasbourg] (CIRDDA), and Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
Psychiatry ,Public health ,Santé publique ,[SDV]Life Sciences [q-bio] ,Quality of Life ,Hépatite C ,Humans ,Hepacivirus ,Hepatitis C, Chronic ,Antiviral Agents ,Hepatitis C ,Psychiatrie - Abstract
International audience; Hepatitis C is a transmissible hepatic and extra-hepatic disease caused by the hepatitis C virus (HCV). HCV develops into a chronic infection among approximately 70% of the contaminated subjects. Chronic HCV infection is estimated to affect between 0.5% and 1 % of the general population in France, which causes an important burden of disease, in particular due to the occurrence of cirrhosis and liver cancer. New antiviral drugs now allow to cure more than 95% of patients in just a few weeks of treatment with very limited safety issues. This therapeutic revolution has led the World Health Organization and many national governments to aim for an elimination of HCV, which has been defined as a 90%-reduction of the incidence rate, and a 65%-reduction in the number of HCV-related deaths on the basis of the 2015 figures. In this respect, the French Ministry of Health has recently decided to extend the ability to prescribe the new antiviral drugs to any physician. However, the elimination campaign of HCV will also need to correctly identify, screen, and treat the main target populations. If people who inject drugs (PWIDs) certainly constitute the most important population concerned by the challenge of HCV elimination, more hidden reservoirs in which HCV transmission can insidiously evolve should be identified and specifically targeted as well. Inpatient psychiatric populations might constitute one of these hidden reservoirs. International data suggest that chronic HCV infection affects approximately 5% of psychiatric inpatients in Europe. This very high prevalence estimate can in part be due to the very frequent psychiatric disorders found among the current or former PWIDs. However, a part of the seropositive patients does not report a history of drug use, and other factors could contribute to the increased risk of contamination in this population including atypical routes of transmission related to institutional promiscuity. Exploring the general profile and risk-behaviors of the psychiatric inpatients found infected by the HCV is thus warranted for future studies. Screening and treating HCV in the specific population of psychiatric patients is part of the general public health objective of eliminating HCV at a national level. Moreover, it also directly fits into the individualized psychiatric care. Many recent data suggest that HCV also has a neural tropism, in particular within glial cells, such as astrocytes or oligodendrocytes. As such, HCV foments inflammatory processes in the brain and contributes to cognitive impairments and psychiatric symptoms such as anxiety or depression. At the individual level, treating HCV infection can improve the psychiatric state and increase patients' outcomes in terms of well-being and quality of life. For all these reasons, the field of psychiatry needs local and national actions for informing and training professionals about HCV screening and treating modalities. Patient and family associations also need to be involved in this general effort of micro-elimination. A key role should be assigned to the general practitioners embedded within inpatient psychiatric units. They are the best fitted professionals to screen, treat, and empower patients, to inform and train other caregivers of the psychiatric field, and to act as a relay with hepatology teams if required. Hospital pharmacists are other important stakeholders. In a national context in which the funding of psychiatric care, including medications, is based on predefined funding envelops, innovative initiatives will have to be set up by local or national health authorities, in partnership with pharmacists, to allow for the treatment of psychiatric inpatients. In conclusion, the world of psychiatry is a possible hidden reservoir of HCV and, as such, a part of the challenge for eliminating the virus. Patients, families, and caregivers will have to be correctly sensitized and trained to play their role in the process. Specific investigations will be required to better understand why such an increased prevalence of HCV is observed in this population. Specific adaptations of the cascade of care within psychiatric settings, including access to treatment, will need to be designed, implemented, and evaluated for reaching micro-elimination of HCV in psychiatry.
- Published
- 2019
5. Abstinence, perceived body and emotion for people with alcohol use disorders
- Author
-
Cyr, L, Pedinielli, J.-L., Cutarella, C., Bréjard, V., Aix-Marseille Université - Faculté des Arts, Lettres, Langues et Sciences Humaines (AMU ALLSH), Aix Marseille Université (AMU), Cliique Saint Barnabé - Ramsay Santé, and Cyr, Laura
- Subjects
[SCCO.PSYC] Cognitive science/Psychology ,[SCCO.PSYC]Cognitive science/Psychology ,ComputingMilieux_MISCELLANEOUS - Abstract
International audience
- Published
- 2019
6. Affectivity, alexithymia and craving: a systematic review.
- Author
-
Cyr, L., Cutarella, C., Pedinielli, J.-L., and Bréjard, V.
- Subjects
- *
ADDICTIONS , *ALEXITHYMIA , *DESIRE , *BORDERLINE personality disorder , *SUBSTANCE abuse - Abstract
Introduction: Craving has been linked to situational and emotional psychological processes (DiFranza et al., 2012) in substance use disorders. Few studies have evaluated the influence of emotional dimensions through affectivity (Watson D, & Clark LA., 1984) on craving (Zuo et al., 2016) and the impact of alexithymia which represents the major disorder of emotional regulation in addiction (Thorberg et al., 2009). Objectives: The main objective of this review is to bring together studies on the emotional dynamic of craving by simultaneously considering affects (negative and positive) and alexithymia. Methods: A systematic review complying with the PRISMA protocol was conducted, and identified 23 studies targetting craving for addictions with substances. Results: As much as 20 of the 23 studies selected show a correlation between affectivity, alexithymia and craving; highlighting 55% of direct links and 48% of partial links. Studies on negative affects (78%) put forth their causal link in the triggering of craving, while studies on positive affectivity (26%) present it as a moderating element in the intensity of craving. Finally, studies on alexithymia (17%) show its effects on emotional reactivity in negative affectivity situations. Conclusions: The results confirm the impact of emotional processes on craving by highlighting the distinct and interdependent roles of negative affectivity, positive affectivity and alexithymia. These aspects of the psychological functioning will therefore have to be target elements in the care. [ABSTRACT FROM AUTHOR]
- Published
- 2020
7. Transmucosal fentanyl-related opioid use disorder in a cancer survivor.
- Author
-
Mezaache S, Cutarella C, Frauger E, and Micallef J
- Published
- 2024
- Full Text
- View/download PDF
8. Association Between Negative Affectivity and Craving in Substance-Related Disorders: A Systematic Review and Meta-analysis of Direct and Indirect Relationships.
- Author
-
Cyr L, Bernard L, Pedinielli JL, Cutarella C, and Bréjard V
- Subjects
- Humans, Attention, Craving, Substance-Related Disorders
- Abstract
Background: A sizeable literature highlighted that negative affectivity and craving are both known to be implicated in relapses., Objectives: The present study synthetized the existing litterature to determine strength of the interaction between negative affectivity and craving for substance-related disorders including illicit drugs, alcohol and tobacco., Methods: We conducted a systematic review in accordance with PRISMA guidelines followed by a meta-analysis. Online computer databases PubMed, PsycINFO and Web of Science were searched systematically and thoroughly. Jamovi 1.8.1 Current version was used to conduct meta-analysis., Results: Thirty studies were included in the review, and 14 of these, including 2257 subjects, were used for meta-analysis. The raw correlation ranged from 0.17 to 0.58, which indicated weak to moderate association between negative affects and craving. In total, approximately 90% of the selection revealed a positive correlation between negative affects and craving. Alcohol and tobacco use disorders have received the most attention. Additionally, negative affectivity was often defined as a transient state rather than a stable personality trait., Conclusions: In both of our meta-analyses and in the narratively reported studies, we found that negative affectivity is an important component related to craving, but individual differences in craving reactivity existed.
- Published
- 2023
- Full Text
- View/download PDF
9. A novel community-based therapeutic education program for reducing alcohol-related harms and stigma in people with alcohol use disorders: A quasi-experimental study (ETHER study).
- Author
-
Barré T, Ramier C, Antwerpes S, Costa M, Bureau M, Maradan G, Di Beo V, Cutarella C, Leloutre J, Riccobono-Soulier O, Hedoire S, Frot E, Vernier F, Vassas-Goyard S, Dufort S, Protopopescu C, Marcellin F, Casanova D, Coste M, and Carrieri P
- Subjects
- Humans, Alcohol Drinking therapy, France, Alcoholism therapy
- Abstract
Introduction: Alcohol use disorder (AUD) is associated with a significant disease burden in France, where alcohol use is deeply rooted in culture. However, the treatment gap is large because of several barriers, including stigmatisation and drinkers' apprehension about total abstinence. However, standardised and evidence-based interventions based on controlled-drinking for people with AUD are lacking. We aimed to assess the effectiveness of a novel community-based French therapeutic patient education (TPE) program for people with AUD named Choizitaconso., Methods: A before-after non-randomised quasi-experimental study, named ETHER, was designed and implemented with people living with AUD, over a period of 6 months. The primary outcome was percentage change in the number of alcohol-related harms experienced. Secondary outcomes were percentage changes in psycho-social patient-reported and community-validated outcomes. Participants in the intervention group (n = 34) benefited from the 10-week TPE program Choizitaconso, while the comparison group (n = 58) received standard care. The Kruskall-Wallis and chi-squared or Fisher's exact tests were used to compare before-after changes in variables in both groups. Linear regression models were used to test for the effect of study group on each outcome and to test for the effect of alcohol consumption as a confounder., Results: At 6 months, all outcomes but one either remained stable or numerically improved in both groups. Internalised stigma significantly improved in the intervention group (p = 0.026) but not in the comparison group (p = 0.207), with a significant group effect (p = 0.014)., Discussion and Conclusions: This study demonstrates the effectiveness of the Choizitaconso TPE program on community-validated outcomes, especially internalised stigma., (© 2023 The Authors. Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs.)
- Published
- 2023
- Full Text
- View/download PDF
10. Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER).
- Author
-
Antwerpes S, Costa M, Coste M, Bureau M, Maradan G, Cutarella C, Leloutre J, Riccobono-Soulier O, Hedoire S, Frot E, Vernier F, Vassas-Goyard S, Barré T, Casanova D, and Carrieri P
- Subjects
- Adult, Alcohol Drinking, Ether, Harm Reduction, Humans, Quality of Life, Alcoholism therapy
- Abstract
Background: ETHER ("Education THEérapeutique pour la Réduction des dommages en alcoologie" or Therapeutic education for alcohol-related harm reduction) is a multicentre community-based mixed-methods study, which aims to evaluate the effectiveness of the innovative therapeutic patient education (TPE) programme 'Choizitaconso' in a sample of French people with alcohol use disorder (people with AUD). Choizitaconso teaches people with AUD psychosocial skills to help them (re)establish controlled drinking and reduce alcohol-related harms. Recruitment started in October 2019. We present here the protocol of the ETHER study., Methods: ETHER's quantitative component involves a 6-month controlled intervention study which evaluates Choizitaconso's effectiveness by comparing 30 people with AUD following the programme with a control group of 60 people with AUD not enrolled in it, using a questionnaire co-constructed by the research team and members of the people with AUD community. Thirty-four alcohol-related harms are assessed and summed to provide an individual measure of the 'harm burden' from consuming alcohol (primary outcome). Secondary outcomes are anticipated and internalized stigma, alcohol consumption measures, craving for alcohol, coping strategies, health-related quality of life, self-confidence to control or abstain from drinking, treatment self-regulation, anxiety and depressive symptoms, alcohol-related neuropsychological impairments, and capabilities (a measure of wellbeing in adults). Data will be collected in face-to-face and phone-based interviews at enrolment and 6 months later. Linear regression models will be used to assess the impact of the TPE programme on changes in the primary and secondary outcomes, while adjusting for other correlates and confounders. The study's qualitative component comprises semi-structured interviews with 16 people with AUD who have already completed the TPE programme at least 6 months before the interview. Qualitative interviews will be analysed using thematic analysis., Results and Conclusions: ETHER is the first evaluation study of an innovative TPE programme specifically designed to reduce alcohol-related harms and reach controlled drinking in France. The involvement of the people with AUD community in selecting which experienced and perceived alcohol-related harms to measure ensures that ETHER will provide healthcare staff and researchers with a relevant set of harm reduction criteria for use in future research. Finally, ETHER will provide scientific justification for implementing novel alcohol-related harm reduction approaches and champion controlled drinking as a therapeutic goal. Trial registration ClinicalTrials.gov, NCT03954054. Registered 17 May 2019-Prospectively registered, https://clinicaltrials.gov/ct2/show/NCT03954054?cond=alcohol&cntry=FR&city=Marseille&draw=1&rank=1 ., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
11. [Hepatitis C in a psychiatric setting: A forgotten reservoir?]
- Author
-
Rolland B, Bailly F, Cutarella C, Drevon O, Carrieri P, Darque A, Hallouche N, Maptue N, Pol S, Llorca PM, and Lang JP
- Subjects
- Antiviral Agents therapeutic use, Hepacivirus, Humans, Quality of Life, Hepatitis C complications, Hepatitis C drug therapy, Hepatitis C epidemiology, Hepatitis C, Chronic complications, Hepatitis C, Chronic drug therapy, Hepatitis C, Chronic epidemiology
- Abstract
Hepatitis C is a transmissible hepatic and extra-hepatic disease caused by the hepatitis C virus (HCV). HCV develops into a chronic infection among approximately 70% of the contaminated subjects. Chronic HCV infection is estimated to affect between 0.5% and 1 % of the general population in France, which causes an important burden of disease, in particular due to the occurrence of cirrhosis and liver cancer. New antiviral drugs now allow to cure more than 95% of patients in just a few weeks of treatment with very limited safety issues. This therapeutic revolution has led the World Health Organization and many national governments to aim for an elimination of HCV, which has been defined as a 90%-reduction of the incidence rate, and a 65%-reduction in the number of HCV-related deaths on the basis of the 2015 figures. In this respect, the French Ministry of Health has recently decided to extend the ability to prescribe the new antiviral drugs to any physician. However, the elimination campaign of HCV will also need to correctly identify, screen, and treat the main target populations. If people who inject drugs (PWIDs) certainly constitute the most important population concerned by the challenge of HCV elimination, more hidden reservoirs in which HCV transmission can insidiously evolve should be identified and specifically targeted as well. Inpatient psychiatric populations might constitute one of these hidden reservoirs. International data suggest that chronic HCV infection affects approximately 5% of psychiatric inpatients in Europe. This very high prevalence estimate can in part be due to the very frequent psychiatric disorders found among the current or former PWIDs. However, a part of the seropositive patients does not report a history of drug use, and other factors could contribute to the increased risk of contamination in this population including atypical routes of transmission related to institutional promiscuity. Exploring the general profile and risk-behaviors of the psychiatric inpatients found infected by the HCV is thus warranted for future studies. Screening and treating HCV in the specific population of psychiatric patients is part of the general public health objective of eliminating HCV at a national level. Moreover, it also directly fits into the individualized psychiatric care. Many recent data suggest that HCV also has a neural tropism, in particular within glial cells, such as astrocytes or oligodendrocytes. As such, HCV foments inflammatory processes in the brain and contributes to cognitive impairments and psychiatric symptoms such as anxiety or depression. At the individual level, treating HCV infection can improve the psychiatric state and increase patients' outcomes in terms of well-being and quality of life. For all these reasons, the field of psychiatry needs local and national actions for informing and training professionals about HCV screening and treating modalities. Patient and family associations also need to be involved in this general effort of micro-elimination. A key role should be assigned to the general practitioners embedded within inpatient psychiatric units. They are the best fitted professionals to screen, treat, and empower patients, to inform and train other caregivers of the psychiatric field, and to act as a relay with hepatology teams if required. Hospital pharmacists are other important stakeholders. In a national context in which the funding of psychiatric care, including medications, is based on predefined funding envelops, innovative initiatives will have to be set up by local or national health authorities, in partnership with pharmacists, to allow for the treatment of psychiatric inpatients. In conclusion, the world of psychiatry is a possible hidden reservoir of HCV and, as such, a part of the challenge for eliminating the virus. Patients, families, and caregivers will have to be correctly sensitized and trained to play their role in the process. Specific investigations will be required to better understand why such an increased prevalence of HCV is observed in this population. Specific adaptations of the cascade of care within psychiatric settings, including access to treatment, will need to be designed, implemented, and evaluated for reaching micro-elimination of HCV in psychiatry., (Copyright © 2020 L'Encéphale, Paris. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
12. Drawing alcohol craving process: A systematic review of its association with thought suppression, inhibition and impulsivity.
- Author
-
Bernard L, Cyr L, Bonnet-Suard A, Cutarella C, and Bréjard V
- Abstract
Alcohol Use Disorder (AUD) is a worldwide public health problem. In recent years, there has been growing evidence supporting craving, the irrepressible desire to drink, as a major mechanism implicated in AUD. Impulsivity is identified as playing a significant role in craving in many studies. However, relationships with inhibition and thought suppression remain unclear in the existing literature. A systematic review was conducted to evaluate their associations in order to better understand the cognitive processes involved in craving. Studies were identified by searching PubMed, PsycINFO and Web of Science using PRISMA procedure and PICOTS framework. There were included if they assessed craving and thought suppression or inhibition or impulsivity, and sample was composed of AUD participants. Thirteen studies were included and were categorized in accordance with the evaluated cognitive process. The first part dealt with thought suppression and the second with impulsivity and inhibition. Four studies showed a positive association between thought suppression and increased craving. Two studies showed that poorer inhibition was associated with increased craving and four studies showed that impulsivity was positively associated with craving. Three studies showed a negative association between impulsivity and inhibition and higher craving. Our review highlights the association of alcohol craving with poorer inhibition and greater impulsivity. Further investigations are needed to give support to different theories and lead to propose an integrative model involving the cognitive process of inhibition in alcohol craving., Competing Interests: The authors declare no conflict of interest., (© 2020 The Authors.)
- Published
- 2021
- Full Text
- View/download PDF
13. Screening and care for alcohol use disorder in France: expectations, barriers and levers using a mixed-methods approach.
- Author
-
Costa M, Barré T, Coste M, Yaya I, Berenger C, Tanti M, Cutarella C, Mora M, Poloméni P, Maynard M, Teuma D, Bazin M, Maradan G, Roux P, and Carrieri PM
- Subjects
- Adult, Alcoholism epidemiology, Female, France epidemiology, Health Services Accessibility, Humans, Male, Middle Aged, Motivation, Qualitative Research, Socioeconomic Factors, Surveys and Questionnaires, Alcoholism prevention & control, Mass Screening psychology
- Abstract
Background: The widespread under-screening and under-treatment of alcohol use disorder (AUD) contributes to its health and socioeconomic burden. We conducted a mixed-methods (qualitative and qualitative) study in people with alcohol use disorder (PWAUD) to explore their expectations, as well as barriers and levers to AUD care., Methods: Individuals with AUDIT > 15 (N = 179) were interviewed using computer-assisted interviews in several medical and non-medical sites (e.g., bars) (quantitative substudy). We also conducted semi-structured face-to-face interviews with 36 PWAUD (qualitative substudy). Using logistic regression, we explored factors associated with having previously received/sought care for AUD. Three major themes were identified in the qualitative textual analysis using a descending hierarchical classification., Results: Not socializing with heavy drinkers (AOR [95%CI]:3.84[1.66-8.85]), regular smoking (9.72[3.91-24.15]) and feeling discriminated against (2.35[1.10-5.05]) were independent levers to having sought/received care for AUD, while being aged < 50 and employment were independent barriers. The five predominant themes in PWAUD discourses emerging from the textual analysis were: drinking context, medical care, alcohol treatment, tobacco/addiction and family. When triangulating results from the logistic regression and the textual analysis, two barriers (social drinking and difficulties with the medical care system), and two levers (family influence and tobacco addiction), emerged., Conclusion: These results underline the need for interventions targeting families and the social network to increase awareness about AUD and related care. Simplified and novel comprehensive care trajectories are urgently needed to reduce the clinical and public health burden of AUD.
- Published
- 2020
- Full Text
- View/download PDF
14. Access to care for people with alcohol use disorder in France: a mixed-method cross-sectional study protocol (ASIA).
- Author
-
Costa M, Marcellin F, Coste M, Barré T, Nordmann S, Mora M, Maradan G, Tanti M, Cutarella C, Casanova D, Levy-Bellaiche S, Polomeni P, Simon N, Roux P, and Carrieri MP
- Subjects
- Cross-Sectional Studies, France, Humans, Qualitative Research, Research Design, Surveys and Questionnaires, Alcoholism therapy, General Practice, Health Services Accessibility
- Abstract
Introduction: Alcohol use disorder (AUD) is a major public health concern worldwide. In France, only 10% of people with AUD (PWAUD) receive medical care. General practitioners (GP) are one of the main entry points for AUD care. The present ongoing study, entitled ASIA (Access to Care and Indifference toward Alcohol, Accès aux Soins et Indifference à l'Alcool in French), aims to improve knowledge about factors associated with access to care for AUD by exploring related GP and PWAUD practices, experiences and perceptions., Methods and Analysis: The ASIA project is an ongoing cross-sectional multisite study based on a complementary mixed-method approach (quantitative and qualitative) using a convergent parallel design. The double-perspective design of the study will enable us to collect and compare data regarding both PWAUD and GP points of view. For the PWAUD quantitative study, 260 PWAUD will be interviewed using a telephone-based questionnaire. For the qualitative study, 36 PWAUD have already been interviewed. The GP quantitative study will include 100 GP in a 15 min survey. Fifteen GP have already participated in semistructured interviews for the qualitative study. Logistic regression will be used to identify predictors for access to care. With respect to data analyses, qualitative interviews will be analysed using semantic analysis while quantitative logistic regression will be used for quantitative interviews., Ethics and Dissemination: This study was approved by the CNIL (French National Commission on Informatics and Liberties) (approval reference number: C16-10, date of approval: 17 July 2017), the CCTIRS (Advisory Committee on Information Processing in Material Research in the Field of Health) and the CEEI (Evaluation and Ethics Committee) (approval reference number: 16-312, date of approval: 8 July 2016) of INSERM (French National Institute of Health and Medical Research). Results from ASIA will be disseminated in peer-reviewed publications, conference presentations, reports and in a PhD thesis., Competing Interests: Competing interests: The commercial company Ethypharm provides financial support, in the form of a salary, to author MCosta., (© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.